Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication
暂无分享,去创建一个
J. Tavernier | N. Kley | S. Plaisance | F. Peelman | A. Cauwels | S. Gerlo | S. Van Lint | G. Uzé | Elianne Burg | Bram Van Den Eeckhout | L. Huyghe